Hans Geinitz
Overview
Explore the profile of Hans Geinitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haderlein M, von der Grun J, Balermpas P, Rodel C, Hautmann M, Steger F, et al.
Front Oncol
. 2024 Sep;
14:1447123.
PMID: 39224800
Background: Current standard treatment concepts in head and neck squamous cell carcinoma (HNSCC) are based on former studies using 2D and 3D treatment plans. However, modern radiation techniques allow for...
2.
Thone P, Egger M, Geroldinger-Simic M, Kindermann H, Kocik L, Karasek N, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543909
Background: Cancer patients are highly prone to infectious diseases. While undergoing antineoplastic treatment, the risk of severe symptoms upon infection increases, necessitating efficient protective measures, such as vaccination. For patients...
3.
Geinitz H, Silberberger E, Spiegl K, Feichtinger J, Wagner H, Hermann P, et al.
Vaccine
. 2024 Jan;
42(4):945-959.
PMID: 38246842
Background: SARS-CoV-2 infection has been and, in some parts, still is a threat to oncologic patients, making it crucial to understand perception of vaccination and immunologic responses in this vulnerable...
4.
Lilleby W, Kishan A, Geinitz H
World J Urol
. 2024 Jan;
42(1):41.
PMID: 38244053
Background: Compelling evidence exists for the iso-effectiveness and safety of moderate hypofractionated radiotherapy (Hypo-RT) schedules [1, 2]. However, international guidelines are not congruent regarding recommendation of ultrahypofractionated radiotherapy (UHF-RT) to...
5.
Rzepka D, Schenker H, Geinitz H, Silberberger E, Kaudewitz D, Schuster B, et al.
Radiat Oncol
. 2023 Jun;
18(1):98.
PMID: 37287050
Background: The risk of developing late radiotoxicity after radiotherapy in patients with high chromosomal radiosensitivity after radiotherapy could potentially be higher compared to the risk in patients with average radiosensitivity....
6.
Bromberger L, Heise B, Felbermayer K, Leiss-Holzinger E, Ilicic K, Schmid T, et al.
PLoS One
. 2023 Mar;
18(3):e0281662.
PMID: 36862637
Background: Inflammatory skin reactions and skin alterations are still a potential side effect in radiation therapy (RT), which also need attention for patients' health care. Method: In a pre-clinical study...
7.
Miron V, Etzelstorfer T, Kleiser R, Raffelsberger T, Major Z, Geinitz H
Strahlenther Onkol
. 2022 Jun;
198(11):1032-1041.
PMID: 35697775
Purpose: For stereotactic radiation therapy of intracranial malignancies, a patient's head needs to be immobilized with high accuracy. Fixation devices such as invasive stereotactic head frames or non-invasive thermoplastic mask...
8.
Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Buttner-Herold M, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008311
Gender is increasingly recognized as an important factor in medicine, although it has long been neglected in medical research in many areas. We have studied the influence of gender in...
9.
Manafi-Farid R, Kupferthaler A, Wundsam H, Gruber G, Vali R, Venhoda C, et al.
J Clin Med
. 2020 Aug;
9(9).
PMID: 32842617
Accurate staging and treatment planning are imperative for precise management in Anal Cancer (ACa) patients. We aimed to evaluate the additive and prognostic value of pre-treatment 2-[F]fluoro-2-deoxy-d-glucose positron emission tomography/computed...
10.
Eggers C, Kopatz V, Dorr W, Lassmann H, Geinitz H
Mult Scler Relat Disord
. 2020 Aug;
45:102443.
PMID: 32827971
Background: Radiation has been discussed as a potential causative factor for Multiple Sclerosis (MS). However, it is unresolved whether radiation increases the aggressiveness of the immune system or whether it...